Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (151-160 of 284) with videos related to

Pageof 29
Sort By:
Chemical Communications (Cambridge, England)|June 16, 2018
Recombinant-fully-human-antibody decorated highly-stable far-red AIEdots for in vivo HER-2 receptor-targeted imagingYayun Wu, Zhizhen Chen, Pengfei Zhang, et al.
The Laryngoscope|January 23, 2014
In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinomaJoel Y Sun, Jiayin Shen, Joel Thibodeaux, et al.
Vaccine|September 25, 2003
Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicityXiaodong Xiao, Sanjay Phogat, Yuuei Shu, et al.
Molecular Cancer Therapeutics|February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surfaceZhewei Tang, Mingqian Feng, Wei Gao, et al.
Experimental and Molecular Pathology|February 4, 2010
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFvKristin Loomis, Brandon Smith, Yang Feng, et al.
Mabs|February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopesYang Feng, Yanping Wang, Zhongyu Zhu, et al.
Cancer Letters|November 6, 2021
A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivoDu-San Baek, Ye-Jin Kim, Sandra Vergara, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaMingqian Feng, Wei Gao, Ruoqi Wang, et al.
Frontiers in Oncology|December 8, 2018
A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid LeukemiaDina Schneider, Ying Xiong, Peirong Hu, et al.
Antibodies (Basel, Switzerland)|November 7, 2019
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoVLili Wang, Jiyan Xu, Yu Kong, et al.
Pageof 29

Showing results (151-160 of 284) with videos related to

Sort By:
Pageof 29
Chemical Communications (Cambridge, England)|June 16, 2018
Recombinant-fully-human-antibody decorated highly-stable far-red AIEdots for in vivo HER-2 receptor-targeted imagingYayun Wu, Zhizhen Chen, Pengfei Zhang, et al.
The Laryngoscope|January 23, 2014
In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinomaJoel Y Sun, Jiayin Shen, Joel Thibodeaux, et al.
Vaccine|September 25, 2003
Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicityXiaodong Xiao, Sanjay Phogat, Yuuei Shu, et al.
Molecular Cancer Therapeutics|February 2, 2013
A human single-domain antibody elicits potent antitumor activity by targeting an epitope in mesothelin close to the cancer cell surfaceZhewei Tang, Mingqian Feng, Wei Gao, et al.
Experimental and Molecular Pathology|February 4, 2010
Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFvKristin Loomis, Brandon Smith, Yang Feng, et al.
Mabs|February 25, 2016
Differential killing of CD56-expressing cells by drug-conjugated human antibodies targeting membrane-distal and membrane-proximal non-overlapping epitopesYang Feng, Yanping Wang, Zhongyu Zhu, et al.
Cancer Letters|November 6, 2021
A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivoDu-San Baek, Ye-Jin Kim, Sandra Vergara, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2013
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinomaMingqian Feng, Wei Gao, Ruoqi Wang, et al.
Frontiers in Oncology|December 8, 2018
A Unique Human Immunoglobulin Heavy Chain Variable Domain-Only CD33 CAR for the Treatment of Acute Myeloid LeukemiaDina Schneider, Ying Xiong, Peirong Hu, et al.
Antibodies (Basel, Switzerland)|November 7, 2019
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoVLili Wang, Jiyan Xu, Yu Kong, et al.
Pageof 29